ERBB2 and breast cancer: According to the results of the Cancer Genome Atlas database analysis, increased expression of sphk1 in HER2-negative breast cancer tissue is associated with increased expression of immune-related molecules, such as TNF-α, IL-6, and transforming growth factor-β, and probably immune cells that suppress tumor immunity, such as Tregs and MDSCs [203].